We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




In Anaphylaxis, Even When in Doubt, Administer Epinephrine

By HospiMedica International staff writers
Posted on 18 Aug 2015
New recommendations by a panel of experts on emergency care calls for appropriate prompt treatment, including the use of epinephrine for all severe allergic reactions.

The panel, which was convened by the American College of Allergy, Asthma and Immunology (ACAAI; Arlington Heights, IL, USA), which included allergologists and emergency physicians, examined barriers to emergency care for anaphylaxis, and discussed ways to encourage appropriate prompt treatment, agreed that epinephrine should be given to patients at risk of an anaphylactic reaction based on a previous severe reaction or to those who have had a known or suspected exposure to their allergic trigger, with or without the development of symptoms.

Another crucial message highlighted by the panel was that anyone seen for anaphylaxis in the emergency room needs to be referred to an allergist for comprehensive follow-up care and guidance for severe allergic reactions. More...
The panel also recommended that allergists and emergency physicians continue to work in partnership, that allergists be proactive in outreach to emergency care practitioners, and that easy-to-access educational programs and materials be developed for use by emergency medical systems and emergency department practitioners in the training environment and in practice. The recommendations were published on August 6, 2015, in Annals of Allergy, Asthma and Immunology.

“Our emergency medicine colleagues told us that if patients don't fit established guidelines for anaphylaxis, there may be a reluctance in the emergency room to treat with epinephrine,” said panel chair allergist Stanley Fineman, MD, past president of the ACAAI. “Because epinephrine is the first line of defense in treating anaphylaxis, the panel agreed it should be used, even if a patient's reaction may not meet all the established criteria. The consequences for not using epinephrine when it's needed are much more severe than using it when it might not be necessary.”

“We want emergency medical personnel, as well as people who have had, or are at risk for having severe allergic reactions to know there is no substitute for epinephrine as the most important tool for combatting anaphylaxis,” added panel member allergist Paul Dowling, MD, of Children's Mercy Hospitals and Clinics (Kansas City, MO, USA). “Antihistamines and corticosteroids should not be given instead of epinephrine because they don't work fast enough.”

Anaphylaxis is a severe allergic reaction that involves a number of body systems, and can be fatal within minutes. It can occur in people with allergies to certain foods, insect stings, medications, latex, or other allergens. All published US national anaphylaxis guidelines recommend epinephrine as the first choice treatment in an acute episode. The vast majority of deaths from anaphylaxis occur in individuals who do not receive epinephrine in a timely manner.

Related Links:

American College of Allergy, Asthma and Immunology
Children's Mercy Hospitals and Clinics



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.